Abstract
The genetic defect of coagulation factor V known as factor V Leiden produces a resistance to degradation by activated protein C (APC) and increases the risk of venous thromboembolism. The data on arterial thrombosis associated with APC resistance are still not clearly defined. We conducted a study in patients presenting with acute myocardial infarction (MI) to assess whether factor V Leiden increases the risk of arterial thrombosis. We studied 109 patients who had a diagnosis of acute MI (69 males and 40 females, aged 25–91 years), and 112 controls. The study population was identified by characteristic ECG changes and elevation of serum CK-MB, whereas the control subjects were anonymous healthy blood donors with no known history of coronary artery disease. Blood samples from the patients and controls were analyzed for the factor V Leiden mutation by DNA analysis, using the polymerase chain reaction. Heterozygous factor V Leiden mutation was found in 9 of 109 (8%) MI patients and 5 of 112 (4%) control subjects (P = .42). In conclusion, this study shows no evidence of an association between factor V Leiden and acute MI.
Similar content being viewed by others
References
Dahlback B. Physiological anticoagulation: Resistance to activated protein C and venus thromboembolism. J Clin Invest 1994;94:923–927.
Dahlback B, Carlsson M, Svenson PJ. Familial thrombophilia due to previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004–1008.
Nichols WL, Heit JA. Activated protein C resistance and thrombosis. Mayo Clin Proc 1996;71:897–898.
Kontula K, Ylikorkala A, Miettinen H. Arg506Gln factor V mutation (Factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost 1995;73:558–560.
Bertina RM, Koeleman BPC, Koster T. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64–67.
Dahlback B. Inherited thrombophilia: Resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995;85:607–614.
Dahlback, B. Resistance to activated protein C, Arg506Gln mutation in factor V gene, and venous thrombosis. Thromb Haemost 1995;73:739–742.
Holm J, Zoller B, Svensson PJ. Myocardial infarction associated with homozygous resistance to activated protein C. Lancet 1994;344:952–954.
Rosendal FR, Siscovick SM, Schwartz RK. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997;89:2817–2821.
Sumani NJ, Lodwick D, Martin D, Kimber P. Evaluation of activated protein C and risk of premature myocardial infarction. Lancet 1994;344:1709–1711.
VanBockxmeer FM, Baker RI, Taylor RR. Premature ischaemic heart disease and the gene for coagulation factor V. Nat Med 1995;1:185–186.
Ardissiono D, Peyvandi F, Merlini PA. Factor V (Arg506-Gln) mutation in young survivors of myocardial infarction. Thromb Haemost 1996;75:701–702.
Marz W, Seydewitz H, Winkelmann B. Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease. Lancet 1995;345: 526–527.
Ridker PM, Hennekens CH, Linpaintner K. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thromboembolism in apparently healthy men. N Engl J Med 1995;332:912–917.
Henkens CMA, Bom VJ, Seinen AJ, van der Meer J. Sensitivity to activated protein C: Influence of oral contraceptives and sex. Thromb Haemost 1995;34402–403.
Coughlin SR. Thrombin receptor structure and function. Thromb Haemost 1993;66:184–187.
Ridker PM, Miletich JP, Hennekens CH. Ethnic distribution of Factor V Leiden in 4047 men and women. JAMA 1997; 277:1305–1307.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gowda, M.S., Zucker, M.L., Vacek, J.L. et al. Incidence of Factor V Leiden in Patients with Acute Myocardial Infarction. J Thromb Thrombolysis 9, 43–45 (2000). https://doi.org/10.1023/A:1018652429633
Issue Date:
DOI: https://doi.org/10.1023/A:1018652429633